Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
The University of Texas MD Anderson Cancer Center · Memorial Sloan Kettering Cancer Center · +26 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
194
total citations
- FWCI
- 27.96
- Percentile
- 100%
- References
- 20
Citations per year
Authors
129- SPShubham Pant
The University of Texas MD Anderson Cancer Center
- MSMartin Schüler
- GIGopa Iyer
Memorial Sloan Kettering Cancer Center, Cornell University
- OWOlaf Witt
German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases
- TDToshihiko Doi
National Cancer Center Hospital East
Topics & keywords
Topics
Keywords
- Medicine
- Oncology
- Internal medicine
- Cohort
- Clinical endpoint
- Response Evaluation Criteria in Solid Tumors
- Cancer
- Performance status
No related works found for this paper.